ROGER JEFFS Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for ROGER JEFFS.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of ROGER JEFFS. ROGER JEFFS is President & CO) in UNITED THERAPEUTICS Corp ($UTHR) and President & Co-CEO in UNITED THERAPEUTICS Corp ($UTHR) and President & COO in UNITED THERAPEUTICS Corp ($UTHR) and President 7 COO in UNITED THERAPEUTICS Corp ($UTHR) and President and COO in UNITED THERAPEUTICS Corp ($UTHR) and Director in SANGAMO THERAPEUTICS, INC ($SGMO) and Director in ALBIREO PHARMA, INC. ($ALBO) and Director in Axsome Therapeutics, Inc. ($AXSM) and Director in Axovant Sciences Ltd. ($AXON) and Director in Dova Pharmaceuticals, Inc. ($DOVA) and Director in Liquidia Corp ($LQDA).
Latest Insider Trading Transactions of ROGER JEFFS
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ALBO, AXSM, DOVA, LQDA, SGMO, AXON, UTHR
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 15 2021 | LQDA | Liquidia Corp | JEFFS ROGER | Director | Buy | P | 2.52 | 99,206 | 249,999 | 111,706 | 12.5 K to 111.7 K (+793.65 %) |
| Mar 26 2021 | LQDA | Liquidia Corp | JEFFS ROGER | Director | Option Exercise | A | 2.51 | 30,353 | 76,186 | 30,353 | |
| Mar 09 2021 | AXSM | Axsome Therapeutic ... | JEFFS ROGER | Director | Option Exercise | A | 65.02 | 1,463 | 95,124 | 1,463 | |
| Jun 19 2020 | ALBO | ALBIREO PHARMA, IN ... | JEFFS ROGER | Director | Option Exercise | A | 27.89 | 8,000 | 223,120 | 8,000 | |
| Jun 05 2020 | AXSM | Axsome Therapeutic ... | JEFFS ROGER | Director | Option Exercise | A | 77.38 | 13,000 | 1,005,940 | 13,000 | |
| Mar 19 2020 | AXSM | Axsome Therapeutic ... | JEFFS ROGER | Director | Option Exercise | A | 45.14 | 4,496 | 202,949 | 4,496 | |
| Mar 19 2020 | AXSM | Axsome Therapeutic ... | JEFFS ROGER | Director | Option Exercise | A | 45.14 | 4,496 | 202,949 | 4,496 | |
| Jan 14 2020 | AXSM | Axsome Therapeutic ... | JEFFS ROGER | Director | Option Exercise | M | 12.95 | 34,866 | 451,515 | 0 | |
| Jan 14 2020 | AXSM | Axsome Therapeutic ... | JEFFS ROGER | Director | Option Exercise | M | 4.95 | 11,000 | 54,450 | 0 | |
| Jan 14 2020 | AXSM | Axsome Therapeutic ... | JEFFS ROGER | Director | Option Exercise | M | 8.02 | 5,193 | 41,648 | 0 | |
| Jan 14 2020 | AXSM | Axsome Therapeutic ... | JEFFS ROGER | Director | Option Exercise | M | 9.00 | 9,127 | 82,143 | 0 | |
| Jan 14 2020 | AXSM | Axsome Therapeutic ... | JEFFS ROGER | Director | Buy | M | 12.95 | 34,866 | 451,515 | 116,806 | 81.9 K to 116.8 K (+42.55 %) |
| Jan 14 2020 | AXSM | Axsome Therapeutic ... | JEFFS ROGER | Director | Buy | M | 4.95 | 11,000 | 54,450 | 81,940 | 70.9 K to 81.9 K (+15.51 %) |
| Jan 14 2020 | AXSM | Axsome Therapeutic ... | JEFFS ROGER | Director | Buy | M | 8.02 | 5,193 | 41,648 | 70,940 | 65.7 K to 70.9 K (+7.90 %) |
| Jan 14 2020 | AXSM | Axsome Therapeutic ... | JEFFS ROGER | Director | Buy | M | 9.00 | 9,127 | 82,143 | 65,747 | 56.6 K to 65.7 K (+16.12 %) |
| Nov 12 2019 | DOVA | Dova Pharmaceutica ... | JEFFS ROGER | Director | Option Exercise | D | 9.36 | 10,000 | 93,600 | 0 | |
| Nov 12 2019 | DOVA | Dova Pharmaceutica ... | JEFFS ROGER | Director | Option Exercise | D | 7.32 | 33,000 | 241,560 | 0 | |
| Nov 12 2019 | DOVA | Dova Pharmaceutica ... | JEFFS ROGER | Director | Sell | D | 0.00 | 66,993 | 0 | 0 | 67 K to 0 (-100.00 %) |
| Jul 05 2019 | AXSM | Axsome Therapeutic ... | JEFFS ROGER | Director | Option Exercise | M | 3.45 | 13,000 | 44,850 | 0 | |
| Jul 05 2019 | AXSM | Axsome Therapeutic ... | JEFFS ROGER | Director | Option Exercise | M | 2.85 | 39,948 | 113,852 | 0 | |
| Jul 05 2019 | AXSM | Axsome Therapeutic ... | JEFFS ROGER | Director | Option Exercise | M | 3.67 | 3,672 | 13,476 | 7,344 | |
| Jul 05 2019 | AXSM | Axsome Therapeutic ... | JEFFS ROGER | Director | Buy | M | 3.45 | 13,000 | 44,850 | 56,620 | 43.6 K to 56.6 K (+29.80 %) |
| Jul 05 2019 | AXSM | Axsome Therapeutic ... | JEFFS ROGER | Director | Buy | M | 2.85 | 39,948 | 113,852 | 43,620 | 3.7 K to 43.6 K (+1,087.91 %) |
| Jul 05 2019 | AXSM | Axsome Therapeutic ... | JEFFS ROGER | Director | Buy | M | 3.67 | 3,672 | 13,476 | 3,672 | 0 to 3.7 K |
| Jul 02 2019 | DOVA | Dova Pharmaceutica ... | JEFFS ROGER | Director | Sell | S | 14.17 | 1,308 | 18,534 | 66,993 | 68.3 K to 67 K (-1.92 %) |
| Jun 25 2019 | ALBO | ALBIREO PHARMA, IN ... | JEFFS ROGER | Director | Option Exercise | A | 31.22 | 5,500 | 171,710 | 5,500 | |
| Jun 25 2019 | ALBO | ALBIREO PHARMA, IN ... | JEFFS ROGER | Director | Option Exercise | A | 31.22 | 5,500 | 171,710 | 5,500 | |
| Jun 10 2019 | AXSM | Axsome Therapeutic ... | JEFFS ROGER | Director | Option Exercise | A | 22.03 | 13,000 | 286,390 | 13,000 | |
| Apr 30 2019 | DOVA | Dova Pharmaceutica ... | JEFFS ROGER | Director | Option Exercise | A | 9.36 | 10,000 | 93,600 | 10,000 | |
| Apr 17 2019 | AXON | Axovant Sciences L ... | JEFFS ROGER | Director | Option Exercise | A | 1.06 | 255,000 | 270,300 | 255,000 | |
| Mar 21 2019 | AXSM | Axsome Therapeutic ... | JEFFS ROGER | Director | Option Exercise | A | 12.95 | 34,866 | 451,515 | 34,866 | |
| Feb 07 2019 | DOVA | Dova Pharmaceutica ... | JEFFS ROGER | Director | Grant | A | 0.00 | 6,901 | 0 | 68,301 | 61.4 K to 68.3 K (+11.24 %) |
| Dec 21 2018 | DOVA | Dova Pharmaceutica ... | JEFFS ROGER | Director | Buy | P | 6.25 | 1,169 | 7,306 | 61,400 | 60.2 K to 61.4 K (+1.94 %) |
| Dec 21 2018 | DOVA | Dova Pharmaceutica ... | JEFFS ROGER | Director | Buy | P | 6.22 | 28,831 | 179,329 | 60,231 | 31.4 K to 60.2 K (+91.82 %) |
| Sep 07 2018 | SGMO | SANGAMO THERAPEUTI ... | JEFFS ROGER | Director | Buy | P | 13.56 | 7,408 | 100,487 | 9,908 | 2.5 K to 9.9 K (+296.32 %) |
| Jun 21 2018 | DOVA | Dova Pharmaceutica ... | JEFFS ROGER | Director | Option Exercise | A | 30.11 | 10,000 | 301,100 | 10,000 | |
| Jun 18 2018 | ALBO | ALBIREO PHARMA, IN ... | JEFFS ROGER | Director | Option Exercise | A | 32.53 | 5,500 | 178,915 | 5,500 | |
| Jun 12 2018 | SGMO | SANGAMO THERAPEUTI ... | JEFFS ROGER | Director | Option Exercise | A | 15.65 | 15,000 | 234,750 | 15,000 | |
| Jun 12 2018 | SGMO | SANGAMO THERAPEUTI ... | JEFFS ROGER | Director | Grant | A | 0.00 | 2,500 | 0 | 2,500 | 0 to 2.5 K |
| Jun 11 2018 | ALBO | ALBIREO PHARMA, IN ... | JEFFS ROGER | Director | Option Exercise | A | 30.68 | 6,500 | 199,420 | 6,500 | |
| Jun 05 2018 | AXSM | Axsome Therapeutic ... | JEFFS ROGER | Director | Option Exercise | A | 3.45 | 13,000 | 44,850 | 13,000 | |
| Apr 05 2018 | AXSM | Axsome Therapeutic ... | JEFFS ROGER | Director | Option Exercise | A | 2.85 | 39,948 | 113,852 | 39,948 | |
| Feb 15 2018 | AXON | Axovant Sciences L ... | JEFFS ROGER | Director | Option Exercise | A | 1.81 | 150,000 | 271,500 | 150,000 | |
| Sep 29 2017 | ALBO | ALBIREO PHARMA, IN ... | JEFFS ROGER | Director | Option Exercise | A | 20.44 | 4,500 | 91,980 | 4,500 | |
| Jul 07 2017 | DOVA | Dova Pharmaceutica ... | JEFFS ROGER | Director | Buy | P | 17.00 | 31,400 | 533,800 | 31,400 | 0 to 31.4 K |
| Jun 29 2017 | SGMO | SANGAMO THERAPEUTI ... | JEFFS ROGER | Director | Option Exercise | A | 8.70 | 30,000 | 261,000 | 30,000 | |
| Mar 30 2017 | AXSM | Axsome Therapeutic ... | JEFFS ROGER | Director | Option Exercise | M | 4.95 | 35,194 | 174,210 | 0 | |
| Mar 30 2017 | AXSM | Axsome Therapeutic ... | JEFFS ROGER | Director | Option Exercise | M | 3.67 | 7,344 | 26,952 | 3,672 | |
| Mar 30 2017 | AXSM | Axsome Therapeutic ... | JEFFS ROGER | Director | Buy | M | 4.95 | 35,194 | 174,210 | 46,912 | 11.7 K to 46.9 K (+300.34 %) |
| Mar 30 2017 | AXSM | Axsome Therapeutic ... | JEFFS ROGER | Director | Buy | M | 3.67 | 7,344 | 26,952 | 11,718 | 4.4 K to 11.7 K (+167.90 %) |
| Mar 17 2017 | AXSM | Axsome Therapeutic ... | JEFFS ROGER | Director | Option Exercise | A | 4.95 | 11,000 | 54,450 | 11,000 | |
| Mar 17 2017 | AXSM | Axsome Therapeutic ... | JEFFS ROGER | Director | Option Exercise | A | 4.95 | 35,194 | 174,210 | 35,194 | |
| Jun 01 2016 | AXSM | Axsome Therapeutic ... | JEFFS ROGER | Director | Option Exercise | A | 8.02 | 5,193 | 41,648 | 5,193 | |
| Mar 15 2016 | UTHR | UNITED THERAPEUTIC ... | JEFFS ROGER | President & Co-CEO | Option Exercise | A | 120.26 | 245,000 | 29,463,700 | 245,000 | |
| Feb 17 2016 | UTHR | UNITED THERAPEUTIC ... | JEFFS ROGER | President & Co-CEO | Option Exercise | M | 65.80 | 9,000 | 592,200 | 0 | |
| Feb 17 2016 | UTHR | UNITED THERAPEUTIC ... | JEFFS ROGER | President & Co-CEO | Sell | D | 126.56 | 9,000 | 1,139,040 | 559 | 9.6 K to 559 (-94.15 %) |
| Feb 17 2016 | UTHR | UNITED THERAPEUTIC ... | JEFFS ROGER | President & Co-CEO | Buy | M | 65.80 | 9,000 | 592,200 | 9,559 | 559 to 9.6 K (+1,610.02 %) |
| Nov 12 2015 | UTHR | UNITED THERAPEUTIC ... | JEFFS ROGER | President & Co-CEO | Option Exercise | M | 61.06 | 4,000 | 244,240 | 94,000 | |
| Nov 12 2015 | UTHR | UNITED THERAPEUTIC ... | JEFFS ROGER | President & Co-CEO | Sell | D | 148.66 | 4,000 | 594,640 | 559 | 4.6 K to 559 (-87.74 %) |
| Nov 12 2015 | UTHR | UNITED THERAPEUTIC ... | JEFFS ROGER | President & Co-CEO | Buy | M | 61.06 | 4,000 | 244,240 | 4,559 | 559 to 4.6 K (+715.56 %) |
| Jan 28 2016 | UTHR | UNITED THERAPEUTIC ... | JEFFS ROGER | President & Co-CEO | Option Exercise | M | 65.80 | 3,000 | 197,400 | 9,000 | |
| Jan 28 2016 | UTHR | UNITED THERAPEUTIC ... | JEFFS ROGER | President & Co-CEO | Sell | D | 125.36 | 3,000 | 376,080 | 559 | 3.6 K to 559 (-84.29 %) |
| Jan 28 2016 | UTHR | UNITED THERAPEUTIC ... | JEFFS ROGER | President & Co-CEO | Buy | M | 65.80 | 3,000 | 197,400 | 3,559 | 559 to 3.6 K (+536.67 %) |
| Jan 26 2016 | UTHR | UNITED THERAPEUTIC ... | JEFFS ROGER | President & Co-CEO | Option Exercise | M | 65.80 | 3,000 | 197,400 | 12,000 | |
| Jan 26 2016 | UTHR | UNITED THERAPEUTIC ... | JEFFS ROGER | President & Co-CEO | Sell | D | 129.44 | 3,000 | 388,320 | 559 | 3.6 K to 559 (-84.29 %) |
| Jan 26 2016 | UTHR | UNITED THERAPEUTIC ... | JEFFS ROGER | President & Co-CEO | Buy | M | 65.80 | 3,000 | 197,400 | 3,559 | 559 to 3.6 K (+536.67 %) |
| Jan 21 2016 | UTHR | UNITED THERAPEUTIC ... | JEFFS ROGER | President & Co-CEO | Option Exercise | M | 65.80 | 3,000 | 197,400 | 15,000 | |
| Jan 21 2016 | UTHR | UNITED THERAPEUTIC ... | JEFFS ROGER | President & Co-CEO | Sell | D | 128.61 | 3,000 | 385,830 | 559 | 3.6 K to 559 (-84.29 %) |
| Jan 21 2016 | UTHR | UNITED THERAPEUTIC ... | JEFFS ROGER | President & Co-CEO | Buy | M | 65.80 | 3,000 | 197,400 | 3,559 | 559 to 3.6 K (+536.67 %) |
| Jan 20 2016 | UTHR | UNITED THERAPEUTIC ... | JEFFS ROGER | President & Co-CEO | Option Exercise | M | 65.80 | 3,000 | 197,400 | 18,000 | |
| Jan 20 2016 | UTHR | UNITED THERAPEUTIC ... | JEFFS ROGER | President & Co-CEO | Sell | D | 133.10 | 3,000 | 399,300 | 559 | 3.6 K to 559 (-84.29 %) |
| Jan 20 2016 | UTHR | UNITED THERAPEUTIC ... | JEFFS ROGER | President & Co-CEO | Buy | M | 65.80 | 3,000 | 197,400 | 3,559 | 559 to 3.6 K (+536.67 %) |
| Jan 14 2016 | UTHR | UNITED THERAPEUTIC ... | JEFFS ROGER | President & Co-CEO | Option Exercise | M | 65.80 | 3,000 | 197,400 | 21,000 | |
| Jan 14 2016 | UTHR | UNITED THERAPEUTIC ... | JEFFS ROGER | President & Co-CEO | Sell | D | 135.82 | 3,000 | 407,460 | 559 | 3.6 K to 559 (-84.29 %) |
| Jan 14 2016 | UTHR | UNITED THERAPEUTIC ... | JEFFS ROGER | President & Co-CEO | Buy | M | 65.80 | 3,000 | 197,400 | 3,559 | 559 to 3.6 K (+536.67 %) |
| Jan 11 2016 | UTHR | UNITED THERAPEUTIC ... | JEFFS ROGER | President & Co-CEO | Option Exercise | M | 65.80 | 4,000 | 263,200 | 24,000 | |
| Jan 11 2016 | UTHR | UNITED THERAPEUTIC ... | JEFFS ROGER | President & Co-CEO | Sell | D | 141.50 | 4,000 | 566,000 | 559 | 4.6 K to 559 (-87.74 %) |
| Jan 11 2016 | UTHR | UNITED THERAPEUTIC ... | JEFFS ROGER | President & Co-CEO | Buy | M | 65.80 | 4,000 | 263,200 | 4,559 | 559 to 4.6 K (+715.56 %) |
| Jan 07 2016 | UTHR | UNITED THERAPEUTIC ... | JEFFS ROGER | President & Co-CEO | Option Exercise | M | 65.80 | 4,000 | 263,200 | 28,000 | |
| Jan 07 2016 | UTHR | UNITED THERAPEUTIC ... | JEFFS ROGER | President & Co-CEO | Sell | D | 147.12 | 4,000 | 588,480 | 559 | 4.6 K to 559 (-87.74 %) |
| Jan 07 2016 | UTHR | UNITED THERAPEUTIC ... | JEFFS ROGER | President & Co-CEO | Buy | M | 65.80 | 4,000 | 263,200 | 4,559 | 559 to 4.6 K (+715.56 %) |
| Jan 05 2016 | UTHR | UNITED THERAPEUTIC ... | JEFFS ROGER | President & Co-CEO | Option Exercise | M | 65.80 | 5,000 | 329,000 | 32,000 | |
| Jan 05 2016 | UTHR | UNITED THERAPEUTIC ... | JEFFS ROGER | President & Co-CEO | Sell | D | 155.54 | 5,000 | 777,700 | 559 | 5.6 K to 559 (-89.94 %) |
| Jan 05 2016 | UTHR | UNITED THERAPEUTIC ... | JEFFS ROGER | President & Co-CEO | Buy | M | 65.80 | 5,000 | 329,000 | 5,559 | 559 to 5.6 K (+894.45 %) |
| Dec 31 2015 | UTHR | UNITED THERAPEUTIC ... | JEFFS ROGER | President & Co-CEO | Option Exercise | M | 65.80 | 5,000 | 329,000 | 37,000 | |
| Dec 31 2015 | UTHR | UNITED THERAPEUTIC ... | JEFFS ROGER | President & Co-CEO | Sell | D | 158.53 | 5,000 | 792,650 | 559 | 5.6 K to 559 (-89.94 %) |
| Dec 31 2015 | UTHR | UNITED THERAPEUTIC ... | JEFFS ROGER | President & Co-CEO | Buy | M | 65.80 | 5,000 | 329,000 | 5,559 | 559 to 5.6 K (+894.45 %) |
| Dec 30 2015 | UTHR | UNITED THERAPEUTIC ... | JEFFS ROGER | President & Co-CEO | Option Exercise | M | 65.80 | 5,000 | 329,000 | 42,000 | |
| Dec 30 2015 | UTHR | UNITED THERAPEUTIC ... | JEFFS ROGER | President & Co-CEO | Sell | D | 160.86 | 5,000 | 804,300 | 559 | 5.6 K to 559 (-89.94 %) |
| Dec 30 2015 | UTHR | UNITED THERAPEUTIC ... | JEFFS ROGER | President & Co-CEO | Buy | M | 65.80 | 5,000 | 329,000 | 5,559 | 559 to 5.6 K (+894.45 %) |
| Dec 28 2015 | UTHR | UNITED THERAPEUTIC ... | JEFFS ROGER | President & Co-CEO | Option Exercise | M | 65.80 | 5,000 | 329,000 | 47,000 | |
| Dec 28 2015 | UTHR | UNITED THERAPEUTIC ... | JEFFS ROGER | President & Co-CEO | Sell | D | 159.90 | 5,000 | 799,500 | 559 | 5.6 K to 559 (-89.94 %) |
| Dec 28 2015 | UTHR | UNITED THERAPEUTIC ... | JEFFS ROGER | President & Co-CEO | Buy | M | 65.80 | 5,000 | 329,000 | 5,559 | 559 to 5.6 K (+894.45 %) |
| Dec 21 2015 | UTHR | UNITED THERAPEUTIC ... | JEFFS ROGER | President & Co-CEO | Option Exercise | M | 65.80 | 5,000 | 329,000 | 52,000 | |
| Dec 21 2015 | UTHR | UNITED THERAPEUTIC ... | JEFFS ROGER | President & Co-CEO | Sell | D | 155.18 | 5,000 | 775,900 | 559 | 5.6 K to 559 (-89.94 %) |
| Dec 21 2015 | UTHR | UNITED THERAPEUTIC ... | JEFFS ROGER | President & Co-CEO | Buy | M | 65.80 | 5,000 | 329,000 | 5,559 | 559 to 5.6 K (+894.45 %) |
| Dec 17 2015 | UTHR | UNITED THERAPEUTIC ... | JEFFS ROGER | President & Co-CEO | Option Exercise | M | 65.80 | 5,000 | 329,000 | 57,000 | |
| Dec 17 2015 | UTHR | UNITED THERAPEUTIC ... | JEFFS ROGER | President & Co-CEO | Sell | D | 159.45 | 5,000 | 797,250 | 559 | 5.6 K to 559 (-89.94 %) |
| Dec 17 2015 | UTHR | UNITED THERAPEUTIC ... | JEFFS ROGER | President & Co-CEO | Buy | M | 65.80 | 5,000 | 329,000 | 5,559 | 559 to 5.6 K (+894.45 %) |
| Dec 14 2015 | UTHR | UNITED THERAPEUTIC ... | JEFFS ROGER | President & Co-CEO | Option Exercise | M | 65.80 | 4,000 | 263,200 | 62,000 | |
| Dec 14 2015 | UTHR | UNITED THERAPEUTIC ... | JEFFS ROGER | President & Co-CEO | Sell | D | 153.16 | 4,000 | 612,640 | 559 | 4.6 K to 559 (-87.74 %) |
| Dec 14 2015 | UTHR | UNITED THERAPEUTIC ... | JEFFS ROGER | President & Co-CEO | Buy | M | 65.80 | 4,000 | 263,200 | 4,559 | 559 to 4.6 K (+715.56 %) |
| Dec 10 2015 | UTHR | UNITED THERAPEUTIC ... | JEFFS ROGER | President & Co-CEO | Option Exercise | M | 65.80 | 4,000 | 263,200 | 66,000 | |
| Dec 10 2015 | UTHR | UNITED THERAPEUTIC ... | JEFFS ROGER | President & Co-CEO | Sell | D | 153.68 | 4,000 | 614,720 | 559 | 4.6 K to 559 (-87.74 %) |
| Dec 10 2015 | UTHR | UNITED THERAPEUTIC ... | JEFFS ROGER | President & Co-CEO | Buy | M | 65.80 | 4,000 | 263,200 | 4,559 | 559 to 4.6 K (+715.56 %) |
| Dec 08 2015 | UTHR | UNITED THERAPEUTIC ... | JEFFS ROGER | President & Co-CEO | Option Exercise | M | 65.80 | 5,000 | 329,000 | 70,000 | |
| Dec 08 2015 | UTHR | UNITED THERAPEUTIC ... | JEFFS ROGER | President & Co-CEO | Sell | D | 158.80 | 5,000 | 794,000 | 559 | 5.6 K to 559 (-89.94 %) |
| Dec 08 2015 | UTHR | UNITED THERAPEUTIC ... | JEFFS ROGER | President & Co-CEO | Buy | M | 65.80 | 5,000 | 329,000 | 5,559 | 559 to 5.6 K (+894.45 %) |
| Dec 03 2015 | UTHR | UNITED THERAPEUTIC ... | JEFFS ROGER | President & Co-CEO | Option Exercise | M | 65.80 | 5,000 | 329,000 | 75,000 | |
| Dec 03 2015 | UTHR | UNITED THERAPEUTIC ... | JEFFS ROGER | President & Co-CEO | Sell | D | 156.76 | 5,000 | 783,800 | 559 | 5.6 K to 559 (-89.94 %) |
| Dec 03 2015 | UTHR | UNITED THERAPEUTIC ... | JEFFS ROGER | President & Co-CEO | Buy | M | 65.80 | 5,000 | 329,000 | 5,559 | 559 to 5.6 K (+894.45 %) |
| Nov 30 2015 | UTHR | UNITED THERAPEUTIC ... | JEFFS ROGER | President & Co-CEO | Option Exercise | M | 65.80 | 4,000 | 263,200 | 80,000 | |
| Nov 30 2015 | UTHR | UNITED THERAPEUTIC ... | JEFFS ROGER | President & Co-CEO | Option Exercise | M | 61.06 | 1,500 | 91,590 | 80,500 | |
| Nov 30 2015 | UTHR | UNITED THERAPEUTIC ... | JEFFS ROGER | President & Co-CEO | Option Exercise | M | 65.80 | 3,500 | 230,300 | 84,000 | |
| Nov 30 2015 | UTHR | UNITED THERAPEUTIC ... | JEFFS ROGER | President & Co-CEO | Sell | D | 154.26 | 4,000 | 617,040 | 559 | 4.6 K to 559 (-87.74 %) |
| Nov 30 2015 | UTHR | UNITED THERAPEUTIC ... | JEFFS ROGER | President & Co-CEO | Buy | M | 65.80 | 4,000 | 263,200 | 4,559 | 559 to 4.6 K (+715.56 %) |
| Nov 30 2015 | UTHR | UNITED THERAPEUTIC ... | JEFFS ROGER | President & Co-CEO | Sell | D | 155.51 | 1,500 | 233,265 | 559 | 2.1 K to 559 (-72.85 %) |
| Nov 30 2015 | UTHR | UNITED THERAPEUTIC ... | JEFFS ROGER | President & Co-CEO | Buy | M | 61.06 | 1,500 | 91,590 | 2,059 | 559 to 2.1 K (+268.34 %) |
| Nov 30 2015 | UTHR | UNITED THERAPEUTIC ... | JEFFS ROGER | President & Co-CEO | Sell | D | 155.51 | 3,500 | 544,285 | 559 | 4.1 K to 559 (-86.23 %) |
| Nov 30 2015 | UTHR | UNITED THERAPEUTIC ... | JEFFS ROGER | President & Co-CEO | Buy | M | 65.80 | 3,500 | 230,300 | 4,059 | 559 to 4.1 K (+626.12 %) |
| Nov 24 2015 | AXSM | Axsome Therapeutic ... | JEFFS ROGER | Director | Option Exercise | A | 5.94 | 4,374 | 25,982 | 0 | |
| Nov 24 2015 | AXSM | Axsome Therapeutic ... | JEFFS ROGER | Director | Buy | C | 5.94 | 4,374 | 25,982 | 4,374 | 0 to 4.4 K |
| Nov 24 2015 | UTHR | UNITED THERAPEUTIC ... | JEFFS ROGER | President & Co-CEO | Option Exercise | M | 61.06 | 4,000 | 244,240 | 82,000 | |
| Nov 24 2015 | UTHR | UNITED THERAPEUTIC ... | JEFFS ROGER | President & Co-CEO | Sell | D | 151.17 | 4,000 | 604,680 | 559 | 4.6 K to 559 (-87.74 %) |
| Nov 24 2015 | UTHR | UNITED THERAPEUTIC ... | JEFFS ROGER | President & Co-CEO | Buy | M | 61.06 | 4,000 | 244,240 | 4,559 | 559 to 4.6 K (+715.56 %) |
| Nov 23 2015 | AXSM | Axsome Therapeutic ... | JEFFS ROGER | Director | Option Exercise | A | 9.00 | 9,127 | 82,143 | 9,127 | |
| Nov 20 2015 | UTHR | UNITED THERAPEUTIC ... | JEFFS ROGER | President & Co-CEO | Option Exercise | M | 61.06 | 4,000 | 244,240 | 86,000 | |
| Nov 20 2015 | UTHR | UNITED THERAPEUTIC ... | JEFFS ROGER | President & Co-CEO | Sell | D | 151.55 | 4,000 | 606,200 | 559 | 4.6 K to 559 (-87.74 %) |
| Nov 20 2015 | UTHR | UNITED THERAPEUTIC ... | JEFFS ROGER | President & Co-CEO | Buy | M | 61.06 | 4,000 | 244,240 | 4,559 | 559 to 4.6 K (+715.56 %) |
| Nov 17 2015 | UTHR | UNITED THERAPEUTIC ... | JEFFS ROGER | President & Co-CEO | Option Exercise | M | 61.06 | 4,000 | 244,240 | 90,000 | |
| Nov 17 2015 | UTHR | UNITED THERAPEUTIC ... | JEFFS ROGER | President & Co-CEO | Sell | D | 146.79 | 4,000 | 587,160 | 559 | 4.6 K to 559 (-87.74 %) |
| Nov 17 2015 | UTHR | UNITED THERAPEUTIC ... | JEFFS ROGER | President & Co-CEO | Buy | M | 61.06 | 4,000 | 244,240 | 4,559 | 559 to 4.6 K (+715.56 %) |
| Nov 09 2015 | UTHR | UNITED THERAPEUTIC ... | JEFFS ROGER | President & Co-CEO | Option Exercise | M | 61.06 | 4,000 | 244,240 | 98,000 | |
| Nov 09 2015 | UTHR | UNITED THERAPEUTIC ... | JEFFS ROGER | President & Co-CEO | Sell | D | 153.62 | 4,000 | 614,480 | 559 | 4.6 K to 559 (-87.74 %) |
| Nov 09 2015 | UTHR | UNITED THERAPEUTIC ... | JEFFS ROGER | President & Co-CEO | Buy | M | 61.06 | 4,000 | 244,240 | 4,559 | 559 to 4.6 K (+715.56 %) |
| Nov 06 2015 | UTHR | UNITED THERAPEUTIC ... | JEFFS ROGER | President & Co-CEO | Option Exercise | M | 61.06 | 4,000 | 244,240 | 102,000 | |
| Nov 06 2015 | UTHR | UNITED THERAPEUTIC ... | JEFFS ROGER | President & Co-CEO | Sell | D | 151.00 | 4,000 | 604,000 | 559 | 4.6 K to 559 (-87.74 %) |
| Nov 06 2015 | UTHR | UNITED THERAPEUTIC ... | JEFFS ROGER | President & Co-CEO | Buy | M | 61.06 | 4,000 | 244,240 | 4,559 | 559 to 4.6 K (+715.56 %) |
| Nov 02 2015 | UTHR | UNITED THERAPEUTIC ... | JEFFS ROGER | President & Co-CEO | Option Exercise | M | 61.06 | 4,000 | 244,240 | 106,000 | |
| Nov 02 2015 | UTHR | UNITED THERAPEUTIC ... | JEFFS ROGER | President & Co-CEO | Sell | D | 146.63 | 4,000 | 586,520 | 559 | 4.6 K to 559 (-87.74 %) |
| Nov 02 2015 | UTHR | UNITED THERAPEUTIC ... | JEFFS ROGER | President & Co-CEO | Buy | M | 61.06 | 4,000 | 244,240 | 4,559 | 559 to 4.6 K (+715.56 %) |
| Oct 30 2015 | UTHR | UNITED THERAPEUTIC ... | JEFFS ROGER | President & Co-CEO | Option Exercise | M | 61.06 | 12,000 | 732,720 | 110,000 | |
| Oct 30 2015 | UTHR | UNITED THERAPEUTIC ... | JEFFS ROGER | President & Co-CEO | Sell | D | 137.15 | 12,000 | 1,645,800 | 559 | 12.6 K to 559 (-95.55 %) |
| Oct 30 2015 | UTHR | UNITED THERAPEUTIC ... | JEFFS ROGER | President & Co-CEO | Buy | M | 61.06 | 12,000 | 732,720 | 12,559 | 559 to 12.6 K (+2,146.69 %) |
| Oct 28 2015 | UTHR | UNITED THERAPEUTIC ... | JEFFS ROGER | President & Co-CEO | Option Exercise | M | 57.15 | 2,500 | 142,875 | 0 | |
| Oct 28 2015 | UTHR | UNITED THERAPEUTIC ... | JEFFS ROGER | President & Co-CEO | Sell | D | 137.10 | 2,500 | 342,750 | 559 | 3.1 K to 559 (-81.73 %) |
| Oct 28 2015 | UTHR | UNITED THERAPEUTIC ... | JEFFS ROGER | President & Co-CEO | Buy | M | 57.15 | 2,500 | 142,875 | 3,059 | 559 to 3.1 K (+447.23 %) |
| Oct 26 2015 | UTHR | UNITED THERAPEUTIC ... | JEFFS ROGER | President & Co-CEO | Option Exercise | M | 61.06 | 3,000 | 183,180 | 122,000 | |
| Oct 26 2015 | UTHR | UNITED THERAPEUTIC ... | JEFFS ROGER | President & Co-CEO | Sell | D | 126.04 | 3,000 | 378,120 | 559 | 3.6 K to 559 (-84.29 %) |
| Oct 26 2015 | UTHR | UNITED THERAPEUTIC ... | JEFFS ROGER | President & Co-CEO | Buy | M | 61.06 | 3,000 | 183,180 | 3,559 | 559 to 3.6 K (+536.67 %) |